Literature DB >> 34928175

Added value of enhanced CT on LR-3 and LR-4 observation of Gd-EOB-DTPA MRI for the diagnosis of HCC: are CT and MR washout features interchangeable?

Kyungjae Lim1, Heejin Kwon1, Jinhan Cho1, Dongwon Kim1, Eunju Kang1, Sanghyeon Kim1.   

Abstract

OBJECTIVE: To characterize the use of portal venous or delayed phase CT as an alternative to estimate washout for the non-invasive diagnosis of hepatocellular carcinoma (HCC) on gadoxetic acid-enhanced MRI in combination with other features.
METHODS: This retrospective study included 226 observations (n = 162 patients) at high risk for HCC imaged with gadoxetic acid-enhanced MRI and enhanced liver CT between March 2015 and March 2018. Two radiologists independently evaluated two sets of images and assigned the final Liver Imaging Reporting and Data System (LI-RADS) categories by consensus using gadoxetic acid-enhanced MRI. LR-1, LR-2, LR-5, and LR-M were excluded from the study.The observations were divided using different criteria for washout: hypointensity on the portal venous phase (PVP) at MRI (criteria 1), hypointensity on PVP at MRI and/or hypoattenuation on the PVP/delayed phase at dynamic CT (criteria 2), and hypointensity on the PVP and/or hepatobiliary phase at MRI (criteria 3). The sensitivity, specificity, and accuracy for the diagnosis of HCC were analyzed for each criterion.
RESULTS: Using gadoxetic acid-enhanced, 226 lesions were diagnosed as LR-3 or LR-4 by LI-RADS. Among them, 98 and 152 had "washout" at criteria 1 and 2, respectively. For the diagnosis of HCC, criteria 2 and 3 showed significantly higher sensitivities (67.3 and 92.5%, respectively) compared with criteria 1 (35.5%) (p < 0.001). The specificity of criteria 3 (13%) was significantly lower than those of criteria 1 and 2 (40.7% and 38.4%, respectively, p < 0.001). The specificities between criteria 1 and 2 were not statistically different (p = 0.427).
CONCLUSION: Although the LI-RADS lexicon does not permit the interchange of image features among various image modalities, the sensitivity of HCC diagnosis could be improved without any decrease in specificity by adding CT image washout features. ADVANCES IN KNOWLEDGE: Although the LI-RADS lexicon does not permit the interchange of image features among various image modalities, complementary use of dynamic CT in LR-3 or LR-4 categories on the basis of gadoxetic acid-enhanced MRI may contribute to major imaging feature.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34928175      PMCID: PMC9153718          DOI: 10.1259/bjr.20210738

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.629


  19 in total

1.  Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.

Authors:  Elizabeth M Hecht; Agnes E Holland; Gary M Israel; Winnie Y Hahn; Danny C Kim; A Brian West; James S Babb; Bachir Taouli; Vivian S Lee; Glenn A Krinsky
Journal:  Radiology       Date:  2006-05       Impact factor: 11.105

Review 2.  Hepatocellular carcinoma imaging systems: why they exist, how they have evolved, and how they differ.

Authors:  An Tang; Irene Cruite; Donald G Mitchell; Claude B Sirlin
Journal:  Abdom Radiol (NY)       Date:  2018-01

Review 3.  Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.

Authors:  Lewis R Roberts; Claude B Sirlin; Feras Zaiem; Jehad Almasri; Larry J Prokop; Julie K Heimbach; M Hassan Murad; Khaled Mohammed
Journal:  Hepatology       Date:  2017-11-29       Impact factor: 17.425

4.  Role of Diffusion Weighted Imaging (DWI) for Hepatocellular Carcinoma (HCC) Detection and its Grading on 3T MRI: A Prospective Study.

Authors:  Shiva Shankar; Naveen Kalra; Anmol Bhatia; Radhika Srinivasan; Paramjeet Singh; Radha K Dhiman; Niranjan Khandelwal; Yogesh Chawla
Journal:  J Clin Exp Hepatol       Date:  2016-09-01

5.  LI-RADS Classification and Prognosis of Primary Liver Cancers at Gadoxetic Acid-enhanced MRI.

Authors:  Sang Hyun Choi; Seung Soo Lee; So Hyun Park; Kang Mo Kim; Eunsil Yu; Yangsoon Park; Yong Moon Shin; Moon-Gyu Lee
Journal:  Radiology       Date:  2018-11-13       Impact factor: 11.105

6.  New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases.

Authors:  Gilles Piana; Ludovic Trinquart; Nawel Meskine; Vincent Barrau; Bernard Van Beers; Valérie Vilgrain
Journal:  J Hepatol       Date:  2010-11-23       Impact factor: 25.083

7.  Accuracy of the diagnostic evaluation of hepatocellular carcinoma with LI-RADS.

Authors:  Weimin Liu; Jie Qin; Ruomi Guo; Sidong Xie; Hang Jiang; Xiaohong Wang; Zhuang Kang; Jin Wang; Hong Shan
Journal:  Acta Radiol       Date:  2017-06-26       Impact factor: 1.990

8.  Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.

Authors:  Melanie K Seale; Onofrio A Catalano; Sanjay Saini; Peter F Hahn; Dushyant V Sahani
Journal:  Radiographics       Date:  2009-10       Impact factor: 5.333

9.  Liver Imaging Reporting and Data System v2014 With Gadoxetate Disodium-Enhanced Magnetic Resonance Imaging: Validation of LI-RADS Category 4 and 5 Criteria.

Authors:  Sang Hyun Choi; Jae Ho Byun; So Yeon Kim; So Jung Lee; Hyung Jin Won; Yong Moon Shin; Pyo Nyun Kim
Journal:  Invest Radiol       Date:  2016-08       Impact factor: 6.016

Review 10.  Cancer stem cells in primary liver cancers: pathological concepts and imaging findings.

Authors:  Ijin Joo; Haeryoung Kim; Jeong Min Lee
Journal:  Korean J Radiol       Date:  2015-01-09       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.